You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML

Showing 51 - 75 of 2,911
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Myeloid Leukemia (AML) Trial in San Francisco (Niclosamide)

Not yet recruiting
  • Acute Myeloid Leukemia (AML)
  • San Francisco, California
    Stanford University
Jun 8, 2022

AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

Recruiting
  • AML
  • MDS
  • Houston, Texas
    M D Anderson Cancer Center
Sep 29, 2022

Adult Patients With Adverse Risk Acute Myeloblastic Leukemia Trial (Darzalex)

Not yet recruiting
  • Adult Patients With Adverse Risk Acute Myeloblastic Leukemia
  • (no location specified)
Feb 27, 2023

Novel Digital Array PCR for Acute Myeloid Leukemia (AML)

Recruiting
  • Leukemia, Myeloid, Acute
  • Minimal Residual Disease
    • Chapel Hill, North Carolina
      North Carolina Cancer Hospital (NCCH)
    Feb 2, 2023

    Acute Myeloid Leukemia Trial in Xuzhou (allogenic NK cells)

    Recruiting
    • Acute Myeloid Leukemia
    • allogenic NK cells
    • Xuzhou, Jiangsu, China
      The Affiliated Hospital of Xuzhou Medical University
    Feb 23, 2023

    Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Gainesville (Ciprofloxacin 750 MG, Etoposide,

    Terminated
    Has Results
    • Leukemia
    • +2 more
    • Ciprofloxacin 750 MG
    • +3 more
    • Gainesville, Florida
      UF Health Shands Cancer Hospital
    Jul 5, 2022

    Relapsed Adult AML Trial in Germany (Venetoclax Oral Tablet)

    Recruiting
    • Relapsed Adult AML
    • Refractory AML
    • Venetoclax Oral Tablet
    • Augsburg, Germany
    • +11 more
    Jan 11, 2023

    UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML) Trial in Wuhan (Basic

    Recruiting
    • UCB (Cord Blood) Microtransplantation in the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
    • Basic chemotherapy + UCB transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Oct 9, 2022

    Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Minneapolis (N-803)

    Completed
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 4, 2023

    Acute Myeloid Leukemia, Mixed Lineage Acute Leukemia, Mixed Lineage Leukemia Gene Mutation Trial (Ziftomenib, Venetoclax,

    Not yet recruiting
    • Acute Myeloid Leukemia
    • +10 more
    • (no location specified)
    Feb 17, 2023

    Adverse Events and Change in Disease Activity in Participants

    Recruiting
    • Acute Myeloid Leukemia (AML)
      • Seoul, Seoul Teugbyeolsi, Korea, Republic of
      • +5 more
      Nov 4, 2022

      Elderly AML Patients, Unfit, New-diagnosis AML, Acute Myeloid Leukemia Trial in Kunming (Experimental: Venetoclax in combination

      Not yet recruiting
      • Elderly AML Patients
      • +4 more
      • Experimental: Venetoclax in combination with Decitabine (+-sorafenib)
      • Active Comparator: Standard dose of Venetoclax + Azacitidine
      • Kunming, Yunnan, China
        The Second Affiliated Hospital of Kunming Medical University.
      Oct 3, 2023

      Acute Myeloid Leukemia, MDS Trial (Galinpepimut-S)

      Available
      • Acute Myeloid Leukemia
      • Myelodysplastic Syndromes
      • Galinpepimut-S
      • (no location specified)
      Oct 20, 2022

      Acute Myeloid Leukemia, Acute Myeloid Leukemia Recurrent, Leukemia Trial in Boston (Cytokine-Induced Memory-like Natural Killer

      Not yet recruiting
      • Acute Myeloid Leukemia
      • +3 more
      • Cytokine-Induced Memory-like Natural Killer Cells
      • +2 more
      • Boston, Massachusetts
      • +1 more
      Nov 22, 2023

      Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Valhalla (Gemtuzumab Ozogamicin)

      Active, not recruiting
      • Acute Myelogenous Leukemia
      • Myelodysplastic Syndrome
      • Gemtuzumab Ozogamicin
      • Valhalla, New York
        New York Medical College
      Sep 26, 2022

      Implantation ofAdvanced Practice Nurse in Complex Care Pathway

      Not yet recruiting
      • Myeloid Leukemia
      • Interviews
      • (no location specified)
      Jul 13, 2022

      Acute Myeloid Leukemia Trial (Sulfasalazine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • (no location specified)
      Oct 11, 2022

      MDS, Myeloid Leukemia, Allogeneic Stem Cell Transplantation Trial in Pittsburgh (IFN-? (interferon gamma-1b) injection)

      Recruiting
      • Myelodysplastic Syndromes
      • +2 more
      • IFN-γ (interferon gamma-1b) injection
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jan 5, 2023

      Leukemia, Myeloid, Acute, Relapsed Adult AML, Refractory Leukemia Trial in Xiamen (venetoclax combining chidamide and

      Recruiting
      • Leukemia, Myeloid, Acute
      • +2 more
      • venetoclax combining chidamide and azacitidine (VCA)
      • Xiamen, Fujian, China
        Bing Xu
      Aug 1, 2022

      Leukemia, Myeloid, Acute, AML Stage, Adult Trial in Xiamen (Venetoclax Combining Chidamide and Azacitidine (VCA) regimen

      Not yet recruiting
      • Leukemia, Myeloid, Acute
      • AML Stage, Adult
      • Venetoclax Combining Chidamide and Azacitidine (VCA) regimen followed by dicitabine combined with liposome mitoxantrone, cytarabine, and G-CSF (D-MAG) regimen
      • Xiamen, Fujian, China
        Bing Xu
      Oct 29, 2022

      Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Granulocytic Sarcoma Trial in Winston-Salem (drug,

      Not yet recruiting
      • Acute Myeloid Leukemia, in Relapse
      • +2 more
      • CPI 613
      • +3 more
      • Winston-Salem, North Carolina
        Wake Forest Baptist Comprehensive Cancer Center
      May 10, 2023

      Acute Myeloid Leukemia Trial in Baltimore (Dose Escalation -tagraxofusp-erzs, Dose Expansion at RP2D -tagraxofusp-erzs)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Dose Escalation -tagraxofusp-erzs
      • Dose Expansion at RP2D -tagraxofusp-erzs
      • Baltimore, Maryland
        The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
      Jan 27, 2023

      AML Patients After Stem Cell Transplant to Understand Relapse

      Recruiting
      • Acute Myeloid Leukemia in Remission
      • Prospective determination of the clinical utility of measurable residual disease (MRD) testing
      • Duarte, California
      • +3 more
      Dec 7, 2022

      Acute Myeloid Leukemia (AML) Trial in Leipzig (VEN+AZA-5)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Leipzig, Germany
        Universitätsklinikum Leipzig, Klinik und Poliklinik für Hämatolo
      Apr 25, 2023

      Acute Myeloid Leukemia, Relapsed Adult AML Trial (Lintuzumab-Ac225, Venetoclax, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Relapsed Adult AML
      • Lintuzumab-Ac225
      • +2 more
      • (no location specified)
      Feb 22, 2022